等待开盘 04-02 09:30:00 美东时间
-0.650
-2.53%
Shares of software-related companies are trading lower following reports sugges...
03-25 00:45
https://event.webcasts.com/starthere.jsp?ei=1752455&tp_key=0c9df3b897&tp_special=8
03-05 00:48
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
9 analysts have shared their evaluations of Intapp (NASDAQ:INTA) during the rec...
02-27 04:00
Stifel analyst Parker Lane maintains Intapp (NASDAQ:INTA) with a Buy and lowers the price target from $40 to $35.
02-26 22:30
Intapp (NASDAQ: INTA), the leading governed AI platform for professional firms in highly regulated industries, announced the launch of Intapp Celeste — a purpose-built agentic AI platform. The new solution was announced
02-26 06:04
ToltIQ, the leading AI-powered platform for private equity due diligence, today announced a partnership with Intapp (NASDAQ:INTA), a global leader in AI-powered solutions for professionals at advisory, capital markets,
02-23 21:29
光通信龙头Lumentum业绩炸裂!周内股价飙涨逾40%;创新药公司MANE上市即翻倍,聚焦脱发口服药物;德州仪器75亿美元收编芯科实验室>>
02-07 11:39
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28